Scott Gottlieb Purchases UnitedHealth Group Shares

Scott Gottlieb acquired 3 shares of UnitedHealth Group on June 23, 2026.

Key Points

  • Scott Gottlieb bought 3 shares of UnitedHealth Group on June 23, 2026.
  • UnitedHealth Group traded near $415.53 on the NYSE with a market cap of $369.3 billion.
  • BlackRock and Vanguard made significant moves in UnitedHealth, while analysts maintain a buy rating.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Scott Gottlieb, a notable figure, bought 3 shares of UnitedHealth Group Incorporated (NYSE: UNH) on June 23, 2026. This transaction wasn't part of a pre-arranged trading plan. On Friday, UnitedHealth's stock traded around $415.53.

Other Institutional Activity in UnitedHealth Group

Several institutional investors have made recent moves in UnitedHealth Group. BlackRock, Inc. reduced its holdings by 1,276,021 shares, bringing its total to 73,467,531 shares valued at approximately $19.88 billion, a 1.7% decrease. Vanguard Capital Management LLC opened a new position with 58,870,777 shares, valued at $15.93 billion. State Street Corp increased its stake slightly by 100,016 shares, ending with 45,332,186 shares worth around $12.27 billion, marking a 0.2% increase. Capital World Investors grew its holding by 5,192,373 shares, totaling 27,783,415 shares valued at $7.52 billion, a 23% increase. Geode Capital Management, LLC boosted its position by 977,105 shares to 22,768,695 shares, valued at $6.14 billion, a 4.5% increase.

UnitedHealth Group Incorporated Stock Up 5.7%

On Friday, UnitedHealth Group's stock was trading near $415.53. The company, with a market capitalization of about $369.3 billion, holds a P/E ratio of 30.65 and a forward P/E of 19.43. It has a beta of 0.65, indicating less volatility compared to the market. The stock's 52-week range is between $234.60 and $415.98, with a 50-day moving average of $372.67 and a 200-day moving average of $333.55. UnitedHealth has a current ratio of 0.798 and a quick ratio of 0.722, alongside a debt-to-equity ratio of 73.98.

Year to date

$UNH stock price

Daily closing prices, year to date. Not investment advice.

Recent Earnings

UnitedHealth Group reported revenue of $449.71 billion, reflecting a 2% growth. The company achieved a net margin of 2.68% and a return on equity of 12.18%. Earnings per share stood at $13.27. The next earnings report is scheduled for July 16, 2026.

Dividend

UnitedHealth Group offers an annual dividend rate of $9.28, yielding 2.31%. The dividend payout ratio is 66.57%.

Insider Buying and Selling at UnitedHealth Group Incorporated

Alongside Scott Gottlieb, several other insiders made purchases on June 23, 2026. Frederick William McNabb III bought 50 shares, Paul Garcia and Charles Baker each acquired 13 shares, Christopher Zaetta, the EVP & Chief Legal Officer, purchased 61 shares, Timothy Patrick Flynn bought 61 shares, and CEO Stephen Hemsley acquired 46 shares. None of these transactions were part of a pre-arranged trading plan.

Analysts Set New Price Targets

On June 24, 2026, B of A Securities maintained its buy rating with a price target of $475. Leerink Partners, on June 17, maintained a buy rating with a $462 target. Earlier in June, Mizuho and JP Morgan both maintained buy ratings with targets of $460 and $466, respectively. The consensus among 26 analysts remains a buy, with an average target price of $409.77.

About UnitedHealth Group

UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, providing a range of healthcare services and products. The company serves patients, healthcare providers, employers, and government entities. UnitedHealth employs approximately 390,000 people and is led by CEO Stephen J. Hemsley.

Bottom Line

Scott Gottlieb's recent purchase of UnitedHealth Group shares is part of broader insider buying activity. UnitedHealth remains a significant player in the healthcare industry, with strong institutional interest and positive analyst ratings. Investors often track these insider transactions for insights, though it's important to remember these filings are backward-looking and may not reflect current positions.

Get UnitedHealth Group Incorporated alerts

New 13F filings, insider trades, and analyst moves on $UNH, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.